Skip to main content
. Author manuscript; available in PMC: 2013 Mar 1.
Published in final edited form as: Hepatology. 2012 Mar;55(3):769–780. doi: 10.1002/hep.24726

Table 2.

Characteristics of Adults with Non-NASH Histology by Race and Ethnicity

Total Population (N=398) Non Latino Black (N=13) Non Latino White (N=302) Latino (N=44) Asian (N=26) Other (N=13) p- value
Age (years)* 46.9 (45.8–48.1) 51.6 (44.3–58.9) 48.4 (47.1–49.6) 38.0 (34.0–42.0) 43.3 (38.2–48.4) 47.1 (40.9–53.2) <0.0001
Gender (%male)# 176 (44) 1 (8) 129 (43) 23 (52) 17 (65) 6 (46) 0.26
BMI (kg/m2)* 33.8 (33.2–34.4) 38.1 (34.5–41.7) 34.1 (33.4–34.8) 33.7 (31.7–35.6) 27.4 (25.8–29.0) 35.4 (32.0–38.7) 0.68
Waist (cm)* 107.3 (105.9–108.6) 111.0 (104.7–117.3) 108.2 (106.6–109.7) 108.0 (103.2–112.8) 92.3 (87.7–96.9) 110.5 (103.8–117.3) 0.90
ALT (U/L)** 57 (53–59) 33 (22–57) 56 (49–58) 60 (51–75) 69 (56–85) 67 (39–123) 0.26
AST (U/L)** 36 (33–38) 27 (22–41) 36 (33–39) 34 (31–42) 39 (32–44) 60 (29–68) 0.94
GGT (U/L)** 40 (36–42) 34 (28–49) 39 (35–42) 38 (31–45) 57 (41–126) 38 (23–60) 0.63
Albumin (g/L)** 4.3 (4.2–4.3) 4.3 (4.0–4.4) 4.3 (4.2–4.3) 4.2 (4.1–4.3) 4.5 (4.3–4.6) 4.5 (4.2–4.8) 0.15
Total bilirubin (mg/dL)** 0.7 (0.7–0.7) 0.5 (0.2–0.7) 0.7 (0.7–0.7) 0.7 (0.6–0.9) 0.9 (0.7–1.1) 0.6 (0.4–0.8) 0.53
Alkaline phosphatase (U/L)** 77 (74–79) 99 (70–117) 78 (75–80) 72 (64–82) 70 (63–87) 86 (57–99) 0.27
Platelets (x 103) ** 252 (246–259) 283 (249–359) 250 (245–258) 252 (227–283) 243 (204–277) 258 (223–329) 0.85
Total cholesterol (mg/dL)** 195 (191–200) 202 (171–234) 196 (192–202) 181 (167–197) 202 (180–209) 190 (157–229) 0.02
Triglyceride (mg/dL)** 147 (135–158) 102 (64–172) 151 (137–162) 122 (103–147) 178 (125–225) 141 (97–218) 0.06
HDL (mg/dL)** 43 (41–44) 58 (41–65) 43 (42–45) 39 (35–42) 41 (36–49) 40 (32–47) 0.03
LDL (mg/dL)** 120 (117–125) 138 (98–162) 121 (118–126) 113 (105–132) 112 (102–122) 128 (92–151) 0.39
Systolic BP (mmHg)** 131 (129–133) 140 (121–152) 132 (130–134) 128 (123–133) 124 (115–130) 140 (124–146) 0.28
Diastolic BP (mmHg)** 77 (75–78) 77 (75–86) 77 (76–79) 76 (71–78) 71 (68–75) 83 (77–88) 0.17
Hypertension (%)# 226 (57) 10 (77) 178 (59) 15 (34) 13 (50) 10 (77) 0.003
Diabetes mellitus (%)# 78 (20) 7 (54) 55 (18) 3 (7) 9 (35) 4 (31) 0.08
Fasting Glucose (mg/dL)** 95 (93.0–97.0) 108 (86.3–144.7) 94 (92.5–96.0) 92 (86.1–95.0) 101 (92.5–110.0) 99 (88.4–156.0) 0.66
Fasting Insulin (microU/L)** 15.2 (14.0–16.0) 20.2 (14.2–38.7) 14.0 (13.0–15.4) 20.0 (16.6–30.8) 14.5 (10.6–21.5) 17.9 (7.7–26.6) <0.0001
HOMA-IR** 3.5 (3.2–3.8) 5.0 (2.7–10.4) 3.2 (2.9–3.5) 5.0 (3.7–6.9) 3.8 (2.6–5.5) 5.1 (1.6–8.2) 0.0002
Hyperlipidemia (%)# 310 (78) 9 (69) 241 (80) 29 (66) 21 (81) 10 (77) 0.05
Metabolic syndrome (%)# 270 (68) 9 (69) 212 (70) 24 (55) 15 (58) 10 (77) 0.06
Family history of NAFLD (%)# 30 (8) 0 (0) 21 (7) 7 (16) 1 (4) 1 (8) 0.07
Acanthosis nigricans (%)# 47 (12) 6 (46) 23 (8) 13 (30) 2 (8) 3 (23) <0.001
Palmar erythema (%)# 33 (8) 1 (8) 30 (10) 1 (2) 0 (0) 1 (8) 0.15
Education (> HS)# 294 (74) 8 (62) 231 (76) 23 (52) 22 (85) 10 (77) 0.002
Income (>$50,000)# 258 (65) 4 (31) 206 (68) 20 (45) 20 (77) 8 (62) 0.004
Total caloric intake (kcal)** 1710 (1608–1799) 1435 (822–2755) 1732 (1635–1822) 1801 (1434–2222) 1230 (1002–1722) 1778 (1238–2394) 0.85
% Calories from fat** 38.9 (38.0–39.9) 37.0 (32.3–44.3) 39.6 (38.3–40.4) 36.8 (34.0–39.7) 39.2 (32.0–43.5) 38.1 (29.4–39.6) 0.06
%Calories from carbohydrates* * 46.9 (45.8–47.7) 52.9 (45.0–58.3) 46.2 (45.2–47.3) 48.6 (44.8–51.5) 45.3 (42.0–56.8) 49.1 (47.4–58.2) 0.13
Physical activity (met hrs/week)** 30.0 (27.6–32.0) 20.0 (15.8–30.6) 29.0 (26.0–32.0) 37.0 (29.1–55.9) 26.9 (11.5–42.5) 34.0 (16.5–65.8) 0.25
*

Mean (95% confidence interval)

**

Median (95% confidence interval)

#

N (%)

Comparing Latino and Non-Latino White individuals